Sangon Biotech

China-based contract research organization (CRO) Sangon Biotech has secured RMB 2 billion (USD 290.3 million) in its first financing round, led by GL Capital. Joining the round are CITIC Private Equity, Greenwoods Investment, Huagai Capital, and Guokai Technology Venture Investment. This significant funding will enable Sangon to accelerate human resource…